Literature DB >> 11223362

Research on the mechanisms of premature ovarian failure.

N Santoro1.   

Abstract

As many as 5% of women may experience menopause at or before age 45 (POF). Four causes are known for POF: (1) Genetic. Clear-cut X chromosome deletions, particularly those in the critical region, result in truncation of reproductive lifespan. Creation of a central genetic data bank for women with POF may assist in defining the genetic contribution to this condition. (2) Autoimmune. POF coexists with virtually all of the permutations of the autoimmune polyglandular failure syndromes, most often in linkage with antithyroid and antiadrenal antibodies. (3) Iatrogenic. Iatrogenic POF results from repeated ovarian surgeries, or from the underlying disease that led to the surgery. (4) Environmental. Environmental toxicants are difficult to pinpoint, but evidence suggests that galactose consumption is linked to early menopause. We investigated the possibility that POF represented premature endocrine aging that was generalized, rather than specifically targeted to the ovary. Detailed investigation of the gonadotropin-releasing hormone-luteinizing hormone system, the somatotrophic axis, the adrenal glucocorticoid and androgen axes, and the prolactin axis have led us to conclude that women with POF are not prematurely aged in any endocrine system other than the ovary. Basic research on how the ovary interacts with the immune system, particularly in the early stages of oogenesis, how the oocyte and follicle interact in fetal life, and how follicles might be protected from damage in the case of immune self-attack are all fruitful avenues of clinically applicable work that may lead to treatments for this most vexing reproductive disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11223362     DOI: 10.1016/s1071-5576(00)00097-6

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  11 in total

Review 1.  Premature menopause or early menopause: long-term health consequences.

Authors:  Lynne T Shuster; Deborah J Rhodes; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Maturitas       Date:  2009-09-05       Impact factor: 4.342

2.  Resveratrol, an effective regulator of ovarian development and oocyte apoptosis.

Authors:  X-X Kong; Y-C Fu; J-J Xu; X-L Zhuang; Z-G Chen; L-L Luo
Journal:  J Endocrinol Invest       Date:  2011-07-07       Impact factor: 4.256

3.  Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.

Authors:  Sara Pinelli; Paolo Giovanni Artini; Stefano Basile; Maria Elena Rosa Obino; Claudia Sergiampietri; Diana Giannarelli; Giovanna Simi; Vito Cela
Journal:  J Assist Reprod Genet       Date:  2017-12-05       Impact factor: 3.412

4.  Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure.

Authors:  Arnaud Lacombe; Hane Lee; Laila Zahed; Mahmoud Choucair; Jean-Marc Muller; Stanley F Nelson; Wael Salameh; Eric Vilain
Journal:  Am J Hum Genet       Date:  2006-05-26       Impact factor: 11.025

5.  FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells.

Authors:  Mira Park; Eunkyoung Shin; Miae Won; Jae-Hong Kim; Hayoung Go; Hyun-Lee Kim; Jeong-Jae Ko; Kangseok Lee; Jeehyeon Bae
Journal:  Mol Endocrinol       Date:  2010-03-05

6.  Autoantibodies to mesothelin in infertility.

Authors:  Judith L Luborsky; Yi Yu; Seby L Edassery; Jade Jaffar; Yuan Yee Yip; Pu Liu; Karl Eric Hellstrom; Ingegerd Hellstrom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

Review 7.  Body composition and cardiometabolic health across the menopause transition.

Authors:  Kara L Marlatt; Dori R Pitynski-Miller; Kathleen M Gavin; Kerrie L Moreau; Edward L Melanson; Nanette Santoro; Wendy M Kohrt
Journal:  Obesity (Silver Spring)       Date:  2022-01       Impact factor: 5.002

Review 8.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

9.  Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis.

Authors:  Gretchen Dole; Eric E Nilsson; Michael K Skinner
Journal:  Reproduction       Date:  2008-02-27       Impact factor: 3.906

10.  Premature ovarian failure risk factors in an Iranian population.

Authors:  Alieh Ghassemzadeh; Laya Farzadi; Elaheh Beyhaghi
Journal:  Int J Gen Med       Date:  2012-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.